1 follower
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together wi... Read more
SpringWorks Therapeutics
6 followers
Freenome
5 followers
Kymera Therapeutics
5 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
4D Molecular Therapeutics
4 followers
Valo
3 followers
Rigel Pharmaceuticals
3 followers
PureTech Health
3 followers
Viridian Therapeutics
2 followers
Gossamer Bio
1 follower
Explore companies